Joong Bae Ahn Selected Research

Joong Bae Ahn Research Topics

Disease

49	Neoplasms (Cancer) 05/2024 - 07/2005
43	Colorectal Neoplasms (Colorectal Cancer) 12/2023 - 04/2006
27	Rectal Neoplasms (Rectal Cancer) 04/2020 - 08/2004
22	Neoplasm Metastasis (Metastasis) 12/2023 - 01/2006
16	Colonic Neoplasms (Colon Cancer) 11/2022 - 04/2006
13	Stomach Neoplasms (Stomach Cancer) 01/2019 - 01/2006
8	Disease Progression 01/2022 - 03/2006
7	Adenocarcinoma 01/2019 - 03/2011
4	Microsatellite Instability 01/2022 - 10/2013
3	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 11/2022 - 01/2022
3	Fatigue 01/2020 - 06/2013
3	Carcinoma (Carcinomatosis) 01/2019 - 04/2009
3	Pathologic Complete Response 12/2016 - 05/2014
3	Breast Neoplasms (Breast Cancer) 10/2014 - 01/2004
2	Margins of Excision 01/2020 - 04/2016
2	Sarcoma (Soft Tissue Sarcoma) 01/2018 - 01/2018
2	Nausea 10/2016 - 10/2014
2	Pain (Aches) 03/2014 - 06/2013
2	Renal Cell Carcinoma (Grawitz Tumor) 10/2013 - 08/2008
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 03/2013 - 01/2008
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2007 - 08/2003
1	Thymoma (Thymic Carcinoma) 10/2021
1	Anaphylaxis (Anaphylactic Shock) 07/2021
1	Head and Neck Neoplasms (Head and Neck Cancer) 07/2021
1	Turcot syndrome 10/2020
1	Anastomotic Leak 04/2020
1	Fecal Incontinence 04/2020

Drug/Important Bio-Agent (IBA)

18	Oxaliplatin (Eloxatin)FDA LinkGeneric 07/2023 - 04/2006
15	Fluorouracil (Carac)FDA LinkGeneric 12/2023 - 03/2006
14	Irinotecan (Camptosar)FDA LinkGeneric 12/2023 - 04/2006
11	Capecitabine (Xeloda)FDA Link 11/2021 - 01/2008
10	Bevacizumab (Avastin)FDA Link 11/2021 - 04/2006
10	Biomarkers (Surrogate Marker)IBA 04/2020 - 11/2008
9	Leucovorin (Folinic Acid)FDA Link 12/2023 - 03/2006
7	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2020 - 02/2013
5	Cetuximab (Erbitux)FDA Link 12/2023 - 04/2006
4	Carcinoembryonic AntigenIBA 08/2020 - 04/2015
4	Messenger RNA (mRNA)IBA 04/2020 - 07/2014
4	XELOXIBA 07/2019 - 01/2012
4	Paclitaxel (Taxol)FDA LinkGeneric 10/2018 - 03/2006
4	Proteins (Proteins, Gene)FDA Link 01/2018 - 05/2011
4	Cisplatin (Platino)FDA LinkGeneric 10/2013 - 01/2008
3	ErbB Receptors (EGF Receptor)IBA 07/2021 - 03/2014
3	taxaneIBA 10/2018 - 09/2007
3	Docetaxel (Taxotere)FDA Link 10/2015 - 11/2008
3	Gemcitabine FDA Link 10/2014 - 08/2003
2	Calcibiotic Root Canal SealerIBA 11/2022 - 01/2016
2	Phosphotransferases (Kinase)IBA 11/2022 - 05/2022
2	TropomyosinIBA 11/2022 - 05/2022
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 10/2021
2	ParaffinIBA 10/2021 - 05/2014
2	Tumor Biomarkers (Tumor Markers)IBA 08/2020 - 01/2017
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 04/2020 - 12/2016
2	Simvastatin (Zocor)FDA LinkGeneric 07/2019 - 09/2009
2	PlatinumIBA 10/2018 - 10/2015
2	Panitumumab (Vectibix)FDA Link 01/2018 - 11/2016
2	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 06/2013 - 06/2008
2	U 0126 (UO 126)IBA 06/2013 - 12/2012
2	Angiogenesis InhibitorsIBA 02/2013 - 10/2010
2	CKD732IBA 04/2012 - 10/2010
2	Complementary DNA (cDNA)IBA 03/2011 - 01/2004
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2008 - 09/2007
1	Therapeutic UsesIBA 05/2024
1	Investigational DrugsIBA 05/2024
1	GC1118IBA 12/2023
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 05/2022
1	tyrosine receptor (receptor, tyrosine)IBA 05/2022
1	Imatinib Mesylate (Gleevec)FDA Link 01/2022
1	Cell-Free Nucleic AcidsIBA 01/2022
1	durvalumabIBA 01/2022
1	Formaldehyde (Formol)FDA Link 10/2021
1	3-amino-1-methyl-3-(4-(3-phenyl-5H- imidazo(1,2- c)pyrido(3,4- e)(1,3)oxazin- 2- yl)phenyl)cyclobutanolIBA 10/2021
1	N- (4- (3- (1H- 1,2,4- triazol- 1- yl)- 4- (3,4,5- trimethoxybenzoyl)phenyl)thiazol- 2- yl)- 2- amino- 3- methylbutanamideIBA 10/2021
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 10/2021
1	Immunoglobulin E (IgE)IBA 07/2021
1	Monoclonal AntibodiesIBA 07/2021
1	Anti-Allergic Agents (Antiallergic Agents)IBA 07/2021
1	Alkaline PhosphataseIBA 12/2020
1	avelumabIBA 10/2020
1	AntigensIBA 01/2020
1	Immune Checkpoint InhibitorsIBA 11/2019
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2019
1	infigratinibIBA 10/2018
1	trifluridine tipiracil drug combinationIBA 01/2018
1	Histones (Histone)IBA 01/2018
1	LK8 peptideIBA 12/2017

Therapy/Procedure

46	Drug Therapy (Chemotherapy) 07/2023 - 08/2003
23	Therapeutics 05/2024 - 08/2004
15	Chemoradiotherapy 04/2020 - 07/2005
14	Radiotherapy 01/2022 - 08/2004
13	Adjuvant Chemotherapy 08/2020 - 04/2006
7	Neoadjuvant Therapy 01/2022 - 07/2005
3	Combination Drug Therapy (Combination Chemotherapy) 10/2013 - 03/2006
2	Consolidation Chemotherapy 01/2018 - 01/2008
2	Metastasectomy 03/2016 - 01/2006
2	Adjuvant Chemoradiotherapy 09/2010 - 08/2004
1	Precision Medicine 05/2024
1	Critical Care (Surgical Intensive Care) 01/2023
1	Immunotherapy 01/2019
1	Re-Irradiation 01/2019